1. A 6-year-old boy recently diagnosed w ith thalassem ia m ajor was started on w hole blood transfusion therapy. Which of the follow ing drugs was m ost likely given during the transfusion to prevent...

1. A 6-year-old boy recently diagnosed w ith thalassem ia m ajor was started on w hole blood transfusion therapy. Which of the follow ing drugs was m ost likely given during the transfusion to prevent transfusional iron overload? A. Ferritin B. Folic acid C. Filgrastim D. Erythropoietin E. Sargram ostim F. Deferoxam ine 2. A 72-year-old m an was adm itted to the hospital w ith a 2-week history of weakness, decreased appetite, and exercise intolerance. Pertinent laboratory values on adm ission w ere red blood cell count 3.0 × 106/mm 3 (norm al, m ale 4.3-5.9 × 106/mm3), m ean corpuscular volum e 96 fL (norm al 80-100 fL), hem oglobin 6 g/dL (norm al, m ale > 13.5 g/dL), serum iron 45 µg/dL (norm al 50-150 µg/dL), serum creatinine 4.7 m g/dL (norm al 0.6–1.2 m g/dL). Which of the following pairs of drugs would be m ost appropriate to treat the patient’s disease? A. Cyanocobalam in and ferrous sulfate B. Erythropoietin and ferrous sulfate C. Erythropoietin and lgrastim D. Cyanocobalam in and iron dextran E. Folic acid and oprelvekin F. Folic acid and iron dextran